Carboplatin and Bevacizumab for Progressive Breast Cancer Brain Metastases
Clinical trial NCT01004172 · COMPLETED
Trial details
- NCT number
- NCT01004172
- Sponsor
- Dana-Farber Cancer Institute
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2009-11-01
- Primary completion
- 2013-12-01
- Enrollment
- 38
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.